ECO Animal Health Group (LON:EAH) Given New GBX 160 Price Target at Shore Capital

ECO Animal Health Group (LON:EAH) had its price objective increased by Shore Capital from GBX 150 to GBX 160 in a research report sent to investors on Tuesday morning,London Stock Exchange reports. Shore Capital currently has a buy rating on the stock.

ECO Animal Health Group Price Performance

LON:EAH traded up GBX 6 during mid-day trading on Tuesday, reaching GBX 104. 79,263 shares of the stock were exchanged, compared to its average volume of 87,180. The company has a current ratio of 2.96, a quick ratio of 2.14 and a debt-to-equity ratio of 4.81. The business has a fifty day moving average price of GBX 89.11 and a 200 day moving average price of GBX 76.26. ECO Animal Health Group has a 1-year low of GBX 50 and a 1-year high of GBX 109.04. The firm has a market capitalization of £70.19 million, a PE ratio of 42.80 and a beta of -0.05.

ECO Animal Health Group (LON:EAH) last posted its quarterly earnings data on Monday, December 1st. The company reported GBX (0.54) earnings per share for the quarter. ECO Animal Health Group had a net margin of 1.17% and a return on equity of 1.27%.

About ECO Animal Health Group

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.

Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.

Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.